Proteomics International Laboratories Ltd. operates as a biological research and drug discovery company. The Company provides analytical, diagnostics services, and therapeutics solutions such as specialist contract research, analytical testing, and consultancy, biomarkers of disease and personalised medicine, and peptide drug discovery from venoms.

Change of Directors' Interest Notices

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Proteomics International Lab (PIQ AU)

Change of Directors' Interest Notices

Notification regarding unquoted securities - PIQ

Notification regarding unquoted securities - PIQ

Investor Presentation

Initial Director's Interest Notice

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)